Clinical Trial Update: Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on biologically modified saphenous vein transplants for coronary artery bypass grafting (CABG) outcomes, conducted in Phase 1 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: St. Luke's Hospital, Chesterfield, Missouri | Conditions: Atherosclerosis | Phase 1, Phase 2 | Status: UNKNOWN